ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
MabThera subkutan 1600 mg/13.4 ml, Lösung zur subkutanen Injektion - 
65813002 PPRoche Pharma (Schweiz) AG
MabThera subkutan 1600 mg/13.4 ml, Lösung zur subkutanen Injektion28.06.2016
  08.05.2018
(L01FA01) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
2023.78Yes
    
10 %2217.40
  
7680658130026Biotechnologika
7435764 
Composition
rituximabum 1600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, methioninum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 13.4 ml.
Packungsbestandteile
Lösung zur subkutanen Injektion 
  
 
Active AgentDose
Rituximab1600mg / 13.4ml
BAG: Active AgentDose
Rituximab1600 mg
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Hyaluronidasum Humanum Adnr
Methionine
Polysorbatum 80
Trehalosum Dihydricum
 
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home